Dr Hernani Costa

Posted on Mar 5 • Originally published at radar.firstaimovers.com

Health OS Architecture: $14.2B Market, AI Premium, EU Compliance

#ai #healthtech #automation #business

The $14.2B digital health funding surge masks a brutal reality: 35% of venture rounds show no step-up, and biological age—not apps—is becoming the outcome metric that drives retention and investor conviction.

Building a Health OS in 2025 requires three simultaneous competencies: multi-source data integration (wearables, labs, environmental sensors), AI-driven insight generation calibrated to regulatory frameworks, and EU AI Act compliance as a defensible moat. This article maps the investment landscape, dissects why Oura succeeded where 23andMe failed, and provides a 10-idea startup matrix ranked by investor appeal and user friction.

HealthTech Investment Landscape (2024–2026)

Market Overview

U.S. digital health startups raised $14.2 billion in 2025, a 35% increase over 2024's $10.5B and the highest total since 2022. However, deal count dropped 5% (482 vs 509 in 2024) while average deal size rose to $29.3M (up from $20.7M). Mega deals ($100M+) accounted for 42% of all funding, the highest proportion since 2021.

This concentration signals a market bifurcation: well-capitalized platforms with defensible moats are consolidating, while seed-stage companies without traction face a narrowing path.

AI Premium

AI-enabled digital health companies captured 54% of total funding in 2025 (up from 37% the prior year) and commanded a ~19% premium on average deal size. At Series C, the "AI premium" reached 61%. Seed-stage AI valuations have seen a ~42% boost since 2021.

Translation for founders: Investors will pay more for AI-native health companies, but expectations for data quality, model validation, and regulatory readiness are correspondingly higher. The AI premium is real, but so is the AI liability if your compliance architecture is weak.

Wellness & Consumer Health Surge

Fitness and wellness startups raised $2.0B across 44 deals, vaulting from the 8th-most funded category in 2024 to 3rd in 2025. Oura's $900M commanded nearly half, but even excluding Oura, the category saw a 13% funding uptick. Multiple companies launched D2C lab testing: Whoop, Oura, Function, Hims, and Superpower.

The pattern: Hardware + subscription + ecosystem expansion (labs, CGM, partners) = platform defensibility.

Seed-Stage Reality for "Health OS" Without Traction

For a seed-stage Health OS ($1–3M raise) without initial traction, the landscape is challenging but navigable:

Provider operations now captures 44% of healthtech funding — the most active subsector.
Seed-stage AI valuations are elevated (~42% above 2021 baseline), meaning investors will pay more for AI-native companies, but expectations are higher.
The "have-not" dynamic is real: 35% of 2025 venture rounds were unlabeled (not a step-up), indicating many companies struggle to progress.
Investor expectation at seed: Advisory board with clinical credibility, pilot LOIs/waitlists, and a clear wedge into a specific use case — not a broad "platform for everything" narrative.

Business Model Analysis: Oura, Whoop, Levels, 23andMe

Oura — The Gold Standard

Metric	Data
Valuation	$11B (Series E, Oct 2025)
Funding	$900M round led by Fidelity
Revenue	$500M in 2024 (doubled YoY), on track for $1B in 2025
Units sold	5.5M rings (>50% in last year)
Market share	~80% of smart ring market
Model	Hardware ($349) + optional subscription ($5.99/mo)

Easy entry point: The ring itself is the hook — a beautiful, simple wearable that "just works" for sleep and readiness. The subscription unlocks advanced insights, and the ecosystem now extends to Dexcom CGM integration and Health Panels (lab testing). Oura is evolving from a sleep tracker into a health platform — the exact "Health OS" trajectory that makes it the reference model.

Why it works: Hardware creates identity and habit. Subscription creates recurring revenue. Ecosystem expansion (labs, CGM, partners) creates lock-in and data moat.

Whoop — Subscription-First, Performance-Focused

Metric	Data
Model	Subscription-only: $199–$359/year
Entry friction	Zero hardware cost — lowest barrier in wearables
Target	Athletes, performance-driven users
Expansion	Added lab testing features in 2025

Why it works: By removing the hardware purchase barrier, Whoop optimizes for trial and conversion. The strain/recovery loop creates daily engagement that justifies the subscription. The brand identity (athletes, biohackers) creates premium positioning.

Easy entry point: "Just put it on and start training" — no purchase decision beyond subscription commitment.

Levels Health — CGM's Difficult Path

Metric	Data
Funding	$38M Series A (2022) at ~$300M valuation
Model	Software layer on top of CGM hardware
Challenge	Non-diabetic CGM utility debated
Market	CGM: $6.32B (2023) → $13.06B by 2032

Why CGM for wellness struggles:

OTC CGM devices (Dexcom Stelo, Abbott Lingo) are commoditizing the hardware.
Medical experts debate usefulness for non-diabetics — "glucose spikes can lead to confusion, anxiety, and disordered eating".
Levels originally wanted to be the "Garmin of CGM" but pivoted to a software/education layer.
CGM requires physical insertion (needle), creating higher friction than a ring or band.
Subscription fatigue compounds with hardware replacement cycles.

Lesson: CGM works as a data input to a broader Health OS, not as a standalone consumer product for the general wellness market.

23andMe — The Cautionary Tale

Metric	Data
Peak valuation	$6B (2021)
Sale price	$305M in bankruptcy (2025)
Users	~15M customers
Failure mode	No recurring revenue, data breach, leadership collapse

What went wrong:

One-shot product: Genetic testing is a single transaction with no natural repeat purchase.
Data breach (7M users compromised in 2023) destroyed trust.
Failed to build a platform: Couldn't convert genetic data into ongoing health value, therapeutics pipeline burned cash.
No "easy entry point": Spit kit → wait weeks → get ancestry results → then what?

Key lesson for Health OS founders: Genetic data alone is not sticky. You need recurring data streams (wearables, labs, daily inputs) that create daily habit loops and continuous value delivery.

Emerging High-Interest Data Points

Biological Age Testing

This is the fastest-growing niche in longevity health tech:

Company	Method	Status	Funding
Generation Lab (SystemAge)	Blood → 19 organ system biological age	275+ clinics, 300M+ data points	$11M seed (Accel)
TruDiagnostic (TruAge)	DNA methylation / epigenetic testing	CLIA-certified, "best bio age test 2025"	Private
Toku (BioAge)	AI retinal imaging → bio age + cardiovascular risk	FDA Breakthrough Device designation	Partnership with Lifeforce
Function Health	100+ biomarkers + MRI (acquired Ezra)	$298M raised, $2.5B valuation	Series B

Why biological age matters for a Health OS: It's the ultimate outcome metric — a single number that captures whether your interventions are working. It creates the "score" that drives engagement and retention.

Retina Scanning for Health Diagnostics

The retina is emerging as a non-invasive window into systemic health:

Toku's CLAiR technology has FDA Breakthrough Device designation with anticipated approval in 2026.
Northwestern's Human Longevity Lab uses AI retinal imaging to estimate biological age and validate anti-aging interventions.
The field is called oculomics — using retinal imaging to detect cardiovascular disease, neurodegeneration, and biological aging.
Life Biosciences (David Sinclair) received FDA approval for the first human trial of age reversal via retinal reprogramming (ER-100).

Opportunity: Retinal scanning requires only a phone camera or standard optometry equipment — far lower friction than blood draws. A Health OS that integrates retinal bio-age with wearable and lab data creates a powerful multi-modal longevity platform.

Environmental Data (Air Quality + IoT)

Smart air quality wearable market: $0.96B (2025) → $2.41B by 2030 (20.2% CAGR).
Air quality apps market projected at $197.8M with 15.3% CAGR.
IoT sensors enable hyper-local, real-time pollution monitoring.
Integration with health platforms via BLE/WiFi is already technically feasible.
Consumer awareness is driving adoption: "66 million tons of pollutants emitted in the US in 2023".

For a Health OS: Environmental exposure data (air quality, UV, temperature, humidity) contextualize wearable data — explaining why your HRV dropped or sleep quality declined. This "environmental layer" is almost entirely unaddressed by current Health OS platforms.

EU Regulatory Requirements for a Health Data Startup

EU AI Act

The EU AI Act entered into force August 2024 and is phasing in over 36 months:

Timeline	What Takes Effect
February 2025	Prohibitions on banned AI practices
August 2025	GPAI obligations (documentation, transparency, copyright)
August 2026	High-risk AI system rules (healthcare, hiring, credit scoring)
August 2027	Grace period ends for pre-existing models

Classification for health AI: Nearly all AI medical devices, diagnostic algorithms, and decision-support tools are classified as "high-risk". This triggers:

Continuous risk management systems
Data governance and bias controls
Human oversight mechanisms (clinicians must be able to override AI)
Detailed logging and transparency documentation
Post-market monitoring obligations
Incident reporting to authorities within 15 days

Penalties: Up to €35M or 7% of global turnover. Other sources cite €30M or 6%.

GDPR Compliance for Clinical/Biometric Data

The AI Act does not replace GDPR — it adds a second compliance layer:

GDPR Requirement	Health OS Implication
Lawful basis for processing	Explicit consent for health/biometric data (Article 9)
Data minimization	Collect only what's necessary for the stated purpose
Purpose limitation	Data collected for health insights can't be repurposed without consent
Right to erasure	Users must be able to delete all their health data
Data portability	Users can export their data in a machine-readable format
DPIA	Required for any large-scale processing of health data
DPO appointment	Likely required for systematic health data processing
Cross-border transfers	Standard Contractual Clauses or adequacy decisions for non-EU processing

The overlap challenge: A company using a biometric AI tool may simultaneously be a controller under GDPR and a deployer under the AI Act, triggering distinct compliance obligations. Providers of biometric AI tools face the most extensive requirements under the AI Act, particularly for high-risk systems.

Security-by-Design Framework

For a European Health OS startup, navigating this complex web requires a robust AI Governance & Risk Advisory framework to ensure compliance from day one. The minimum compliance architecture includes:

HIPAA-equivalent protections (if serving US users): encryption at rest/in transit, access controls, audit logs
SOC 2 Type II certification: demonstrates security controls over time
GDPR Article 25: Data protection by design and by default
AI Act Article 9: Data governance — training data must be representative, bias-free, and auditable
ISO 27001/27701: Information security and privacy management standards
FHIR/HL7 compliance: For clinical data interoperability

Top 10 Health OS Startup Ideas (Ranked by Investor Appeal + Low User Friction)

Idea 1: "BioAge Dashboard" — Unified Biological Age Tracker

Concept: Aggregate data from wearables (Oura, Whoop, Garmin), blood biomarkers, and optional advanced tests (DNA methylation, retinal scan) into a single biological age score with organ-system breakdown.

Current Gap: Generation Lab does biological age from blood only. Function Health does labs + MRI. No one unifies wearable data + labs + advanced bio-age tests into one longitudinal dashboard with AI-driven recommendations.

AI Possibilities: Fine-tune an open-source model (BioMistral or OpenBioLLM) on published longevity research to generate personalized intervention recommendations. Use the continuous wearable data stream to validate whether interventions are actually moving the bio-age needle.

Seed Opportunity: $1.5–3M. The "biological age" narrative is hot (Generation Lab raised $11M seed, Blueprint raised $60M). Lead with the insight layer, not the hardware.

Easy Entry Point: Connect your Oura/Whoop + order a home blood kit → get your BioAge score in 48 hours.

Idea 2: "EnviroHealth" — Personal Environmental Exposure Platform

Concept: Combine wearable health data with hyperlocal environmental data (air quality, UV, pollen, water quality, noise) to contextualize health patterns and provide exposure-adjusted recommendations.

Current Gap: Air quality wearable market is $0.96B growing to $2.41B, but no platform connects environmental exposure to personal wearable health metrics. Your HRV crashed — was it stress, or was it the PM2.5 spike in your neighborhood?

AI Possibilities: Use location data + IoT air quality APIs + weather APIs to build an "environmental exposure profile" that layers onto wearable data. Open-source LLMs can interpret the combined signal.

Seed Opportunity: $1–2M. Novel angle, defensible data moat (environmental + health correlation dataset), strong EU regulatory narrative (right to clean air).

Easy Entry Point: Connect your wearable + share location → get your daily Environmental Health Score.

Idea 3: "MetaboLoop" — CGM + Nutrition AI Co-Pilot

Concept: Integrate CGM data (Dexcom Stelo OTC, Abbott Lingo) with MyFitnessPal/nutrition tracking and wearable activity data to create a real-time metabolic optimization engine.

Current Gap: Levels tried but couldn't build recurring value beyond the CGM subscription. Oura now sells Dexcom CGMs but doesn't deeply integrate the glucose signal. No one closes the loop: meal → glucose response → activity context → personalized recommendation → validated outcome.

AI Possibilities: Train a domain-specific model on published glycemic index research + user data to predict individual glucose responses to specific foods + activity combinations. The data flywheel improves predictions with each user.

Seed Opportunity: $1.5–2.5M. CGM going OTC is the unlock. The software layer on top of commoditized CGM hardware is where the value accrues.

Easy Entry Point: Snap a photo of your meal + wear a CGM → get real-time metabolic coaching.

Idea 4: "CareGraph" — Family Health Intelligence Platform

Concept: A multi-user health platform designed for families — track aging parents, kids' development milestones, your own longevity metrics, and coordinate care across household members.

Current Gap: All current Health OS platforms (Function, Superpower, Oura) are single-user. Savoy Life raised funding for caregiving but focused only on elderly care. No platform serves the whole family unit with shared dashboards and coordinated alerts.

AI Possibilities: Use LLMs to synthesize family health histories, detect hereditary risk patterns, and generate family-wide health recommendations. Agentic AI can coordinate appointments, medication reminders, and care handoffs.

Seed Opportunity: $1.5–2.5M. Strong emotional narrative (protecting your family), clear distribution (one buyer, multiple users = viral loop), addressable by employer wellness benefits.

Easy Entry Point: Create a family circle → connect each member's wearable or manually log → get family health insights.

Idea 5: "SleepStack" — Deep Sleep Optimization Engine

Concept: The first platform laser-focused on sleep optimization by combining Oura/Whoop sleep data, environmental sensors (light, temperature, air quality, noise), supplement tracking, and clinical sleep medicine.

Current Gap: Oura and Whoop track sleep but don't prescribe interventions beyond generic advice. Eight Sleep controls temperature but doesn't integrate with other data. No platform unifies environmental controls + wearable data + evidence-based intervention protocols.

AI Possibilities: Build a recommendation engine that correlates sleep architecture (from wearable) with environmental conditions, nutrition, activity, and supplements to identify each user's optimal sleep protocol. Open-source LLMs can reference clinical sleep medicine literature.

Seed Opportunity: $1–2M. Sleep is the #1 reason people buy Oura rings. A dedicated sleep optimization layer that works across devices taps into massive existing demand.

Easy Entry Point: Connect your sleep tracker → answer 5 questions → get your personalized Sleep Protocol.

Idea 6: "LongevOS" — Longevity Protocol Marketplace + Tracker

Concept: Curate and track evidence-based longevity protocols (Bryan Johnson's Blueprint, Attia's frameworks, Huberman's stacks) with biomarker validation — an "operating system for longevity enthusiasts."

Current Gap: Blueprint raised $60M selling its own protocol, but there's no neutral platform that lets users compare, track, and validate multiple protocols against their own biomarkers. The longevity community is fragmented across podcasts, subreddits, and influencer stacks.

AI Possibilities: Build a longevity knowledge graph from published research + popular protocols. AI agent recommends protocol adjustments based on individual biomarker trajectories. Community data creates a benchmark: "people with your profile who followed Protocol X saw Y% improvement."

Seed Opportunity: $1.5–3M. The longevity market is exploding: Fountain Life ($18M Series B), NewLimit ($130M Series B), Generation Lab ($11M seed).

Easy Entry Point: Pick a protocol (or build your own) → connect wearable + labs → track progress against community benchmarks.

Idea 7: "NeuroTrack" — Cognitive Health + Brain Age Platform

Concept: Combine wearable data (HRV, sleep), cognitive assessments (gamified tests), retinal imaging (via Toku-style partnerships), and lifestyle data to generate a "Brain Age" score and cognitive optimization plan.

Current Gap: Retinal imaging can detect neurological aging, wearables track sleep quality (critical for cognitive health), but no platform synthesizes these signals into a cognitive health score. Nyra Health raised $49M for digital neurotherapy — proving investor appetite.

AI Possibilities: Use oculomics research + sleep architecture data + cognitive test results to build a multimodal brain health model. Fine-tune on published neurological research.

Seed Opportunity: $2–3M. Alzheimer's/dementia prevention is a trillion-dollar problem. Early detection + intervention tracking is deeply fundable.

Easy Entry Point: Take a 5-minute cognitive game + connect your sleep tracker → get your Brain Age score.

Idea 8: "WorkWell" — Occupational Health OS for Remote Workers

Concept: A B2B2C platform for employers that integrates wearable data, ergonomic assessments, screen time, stress metrics, and environmental factors (home office air quality, light) to optimize employee health and productivity.

Current Gap: Corporate wellness programs are generic. No platform combines wearable biometrics + work patterns + environmental data specifically for knowledge workers. Pro-Tier launched employer-subsidized benefits but without deep biometric integration.

AI Possibilities: Correlate meeting patterns, screen time, HRV, and activity data to predict burnout risk and recommend interventions. AI coach that nudges movement, hydration, and recovery breaks.

Seed Opportunity: $1.5–2.5M. B2B distribution reduces CAC. Employer-paid model (HSA/FSA eligible). Clear ROI narrative: reduced sick days, improved productivity.

Easy Entry Point: Employer signs up → employees connect wearable + work calendar → get personalized wellness nudges.

Idea 9: "FemOS" — Women's Health Intelligence Platform

Concept: A women-specific Health OS that tracks hormonal cycles, fertility markers, menopause transitions, and integrates with wearables, lab work, and nutrition data to provide phase-specific health recommendations.

Current Gap: Oura added period tracking but it's surface-level. Hematica targets female athletes. No comprehensive platform combines cycle tracking + wearable biometrics + lab work (hormones, thyroid, iron) + AI recommendations calibrated to hormonal phases.

AI Possibilities: Train models on hormonal phase research to provide cycle-phase-specific nutrition, exercise, and supplement recommendations. Predictive models for fertility windows and menopause transition.

Seed Opportunity: $1.5–3M. Women's health is chronically underfunded despite massive market. Cyclana Bio raised £5M pre-seed for women's health biotech. Strong narrative for impact-focused investors.

Easy Entry Point: Log your cycle + connect wearable → get phase-specific daily recommendations.

Idea 10: "EcoVital" — European-First Preventive Health Platform

Concept: A GDPR-native, EU AI Act-compliant Health OS built specifically for the European market — integrating wearables, lab testing (via European lab networks), and AI insights with full regulatory compliance as a feature, not a burden.

Current Gap: Most Health OS platforms (Function, Superpower, Mito) are US-centric. Holo (Barcelona) and Autonome (Paris) are exploring European visions but are early-stage. No platform owns "the European Health OS" positioning with compliance as a moat.

AI Possibilities: Deploy open-source medical LLMs (BioMistral, OpenBioLLM) on EU-hosted infrastructure for full data sovereignty. Use the EU AI Act's high-risk framework as a competitive moat — certification that US competitors can't easily replicate.

Seed Opportunity: $1.5–2.5M. Strong narrative: "We built this for Europe, by Europe, with European values." EU grants (Horizon Europe, EIC Accelerator) can supplement VC funding. The ACCESS Model in the US has no EU equivalent yet — first mover advantage.

Easy Entry Point: Connect your wearable + visit a partner lab → get your Health Score, fully GDPR-compliant.

Gap / Possibility / Opportunity Matrix

#	Idea	Current Gap	AI Scaling Possibility	Seed Funding Opportunity
1	BioAge Dashboard	No unified bio-age from wearable + labs + advanced tests	Fine-tuned longevity LLM; data flywheel validates interventions	$1.5–3M; "biological age" is the hottest longevity narrative
2	EnviroHealth	No environmental + health data correlation platform	Location-aware AI contextualizes wearable anomalies	$1–2M; novel angle, defensible data moat
3	MetaboLoop	CGM software layer commoditized; no closed metabolic loop	Individual glucose response prediction model	$1.5–2.5M; OTC CGM is the unlock
4	CareGraph	All Health OS platforms are single-user	Family health pattern detection, hereditary risk	$1.5–2.5M; multi-user viral loop
5	SleepStack	Sleep trackers don't prescribe; no environment integration	Intervention correlation engine across data streams	$1–2M; sleep is #1 wearable use case
6	LongevOS	No neutral protocol tracker with biomarker validation	Longevity knowledge graph + community benchmarks	$1.5–3M; longevity market exploding
7	NeuroTrack	No multimodal cognitive health platform	Oculomics + sleep + cognitive test fusion model	$2–3M; Alzheimer's prevention is trillion-dollar problem
8	WorkWell	Corporate wellness is generic, no biometric integration	Burnout prediction from wearable + work pattern data	$1.5–2.5M; B2B distribution, employer-paid
9	FemOS	Women's health data fragmented, cycle-blind recommendations	Hormonal phase-calibrated recommendation engine	$1.5–3M; underserved market, impact narrative
10	EcoVital	No Europe-first GDPR-native Health OS	Open-source medical LLMs on EU infrastructure	$1.5–2.5M; regulatory moat + EU grants

System Prompt Blueprint: AI-Driven Health OS

This is a comprehensive system prompt blueprint for an AI Health OS that ingests multi-source data and generates actionable health insights.

System Architecture Overview

┌─────────────────────────────────────────────────┐
│ USER INTERFACE │
│ (Mobile App / Web Dashboard / Voice Agent) │
├─────────────────────────────────────────────────┤
│ AI REASONING ENGINE │
│ ┌──────────┐ ┌──────────┐ ┌──────────┐ │
│ │ Health │ │ Insight │ │ Action │ │
│ │ Profile │ │ Generator│ │ Recommender│ │
│ │ Builder │ │ │ │ │ │
│ └──────────┘ └──────────┘ └──────────┘ │
├─────────────────────────────────────────────────┤
│ DATA NORMALIZATION LAYER │
│ FHIR/HL7 mapping │ Unit conversion │ Deduplication│
├─────────────────────────────────────────────────┤
│ DATA INGESTION LAYER │
│ ┌────┐ ┌────┐ ┌─────┐ ┌────┐ ┌────┐ ┌─────┐ │
│ │Oura│ │Whoop│ │Garmin│ │CGM │ │Labs│ │Apps │ │
│ └────┘ └────┘ └─────┘ └────┘ └────┘ └─────┘ │
└─────────────────────────────────────────────────┘

Open-Source Model Strategy

For the AI reasoning engine, use a layered model approach. This approach allows for the development of custom AI solutions without vendor lock-in.

Layer	Model	Purpose
General health reasoning	OpenBioLLM-70B (outperforms GPT-4 on biomedical benchmarks)	Primary inference engine for health insights
Medical literature retrieval	BioMistral 7B (lightweight, PubMed-trained)	Evidence retrieval and citation generation
Clinical note interpretation	MedLlama2 (open-source, customizable)	Lab result interpretation and clinical context
Conversational interface	Fine-tuned Llama 3 or Mistral	User-facing chat with safety guardrails

Deployment: Self-hosted on EU infrastructure (Hetzner, OVH, or Scaleway) for full GDPR data sovereignty. Use ONNX/vLLM for inference optimization. Quantized 4-bit models for edge deployment on mobile devices for latency-sensitive features.

Pitch Deck Structure for AI Health OS Startup

This is a 16-slide deck structure (14 core + 2 healthcare-specific modules) aligned with the YC seed deck framework, Sequoia's classic outline, and the healthcare-specific secrets identified in the earlier research.

Slide 1: One-Line Promise

"We turn your scattered health data into a single biological age score and a personalized protocol to reverse it."

Design: Full-screen, bold text. Company logo. One sentence. No clutter.

Slide 2: The Problem

"Your body generates 1,000+ health data points per day. Zero of them talk to each other."

Show the fragmentation:

Oura tracks sleep → in one app
Garmin tracks runs → in another app
CGM tracks glucose → in yet another
Lab results → in a PDF from your doctor
MyFitnessPal → separate food diary

Quantify: "The average health-conscious consumer uses 3.7 health apps that never share data. $400B is spent annually on preventable chronic disease."

Slide 3: Why Now

Four converging forces:

OTC CGMs are now available without prescription (Dexcom Stelo, Abbott Lingo)
Oura/Whoop APIs enable third-party data access at scale
Open-source medical LLMs (BioMistral, OpenBioLLM) make AI reasoning affordable
Biological age testing is going mainstream ($11M seed for Generation Lab)
EU AI Act creates a regulatory moat for compliant platforms (Aug 2026 deadline)

Slide 4: The Solution

"[Company Name] is the Health Operating System that connects your wearables, labs, and lifestyle data to generate your Biological Age and a personalized protocol to optimize it."

One diagram: Data inputs → Normalization → AI Engine → BioAge Score + Daily Protocol

Slide 5: How It Works in the Real World

Product screenshots showing:

Onboarding: "Connect Oura + order blood kit" (2-minute setup)
Dashboard: Biological age, organ system scores, daily protocol
Daily insight: "Your HRV is 12% below baseline. Based on your glucose and sleep data, here's what likely caused it and what to do today."
Weekly report: Trend visualization, protocol adjustments

Slide 6: The Data Flywheel ⭐ (Key Differentiator Slide)

More Users → More Data → Better AI Predictions →
Better Outcomes → Higher Retention → More Users

Explain each flywheel component:

Data diversity: Each user adds wearable + lab + lifestyle + environmental data combinations no single device captures
Prediction accuracy: The model learns which interventions work for which user profiles (N-of-1 trials at scale)
Benchmark value: "People with your BioAge who followed Protocol X improved by Y%" — this insight is only possible with community data
Switching cost: Once your longitudinal health data lives in the platform, leaving means losing years of context

Show the compounding math: "At 10K users, our model sees X correlations. At 100K users, we see 10X. At 1M, we see patterns no human researcher could detect."

Slide 7: Proof / Early Traction

Stage-appropriate evidence:

Pre-seed: Advisory board (longevity MDs, wearable engineers), waitlist size, pilot LOIs
Seed: Beta users, retention metrics, early NPS, engagement data (daily active users checking BioAge)
Post-seed: Revenue, clinical outcomes from pilot ("users who followed AI protocol for 90 days reduced biological age by X")

Slide 8: Clinical Evidence Plan

What you're measuring: biological age delta, biomarker improvement rates, protocol adherence
How: IRB-approved observational study with partner longevity clinic
With whom: Named clinical partners
Timeline: Phase 1 (pilot data) → Phase 2 (published case series) → Phase 3 (RCT if pursuing SaMD)

Slide 9: Market & Wedge

Start narrow, expand:

Wedge: Health-conscious early adopters who already own Oura/Whoop (estimated 10M+ globally)
SAM: Preventive health market ($659B digital health, 25.1% CAGR)
TAM: Global wellness economy ($5.6T)

Show the wedge expansion: Biohackers → Longevity enthusiasts → Employer wellness → Health insurance partners → Clinical integration

Slide 10: Business Model

Revenue Stream	Pricing	Who Pays
Core subscription	$19.99/mo or $149/yr	Consumer (D2C)
Premium tier (lab integration + AI coaching)	$29.99/mo or $249/yr	Consumer
Enterprise/employer	$8–15/employee/mo	Employer (B2B2C)
Lab test marketplace	Commission per test	Lab partners
Data insights (anonymized, aggregate)	Licensing fee	Research institutions

Unit economics: Target LTV:CAC > 4:1, gross margin > 75% (software), net retention > 110%.

Slide 11: Go-to-Market

Community-led growth: Partner with longevity podcasts (Attia, Huberman), biohacker communities, r/longevity
Wearable integration partnerships: "Works with Oura/Whoop/Garmin" positioning
Influencer seeding: Send beta access to longevity influencers (Bryan Johnson effect)
B2B2C: Employer wellness programs (HSA/FSA eligible)
European expansion: GDPR compliance as selling point, EU grants (EIC Accelerator)

Slide 12: Compliance Architecture ⭐ (EU AI Act Slide)

"Regulation is our moat, not our burden."

Visual showing three-layer compliance stack:

GDPR Layer: Data sovereignty (EU-hosted), consent management, right to erasure, data portability (FHIR export)
EU AI Act Layer: High-risk AI classification readiness, risk management system, human oversight (clinician review for flagged insights), transparency documentation, post-market monitoring
Security Layer: SOC 2 Type II, encryption at rest/in transit, zero-knowledge architecture, ISO 27001 certification path

Timeline: "High-risk AI rules take effect August 2026. We'll be certified before competitors even start compliance."

Key message: US competitors will need 18–24 months to retrofit compliance. We're building it in from day one.

Slide 13: Competition & Alternatives

2x2 matrix:

X-axis: Data breadth (single source → multi-source)
Y-axis: AI intelligence (raw data → actionable insights)

Plot competitors:

Oura: High single-source data, medium AI (improving)
Function Health: High lab data, low wearable integration
Whoop: High single-source, medium AI
Apple Health: Broad but shallow, no AI reasoning
[You]: Upper right — multi-source + AI-driven insights + BioAge outcome metric

Include "do nothing" and "DIY spreadsheet" as real alternatives.

Slide 14: Moat

Data flywheel: Multi-source correlation dataset no single device company can replicate
EU compliance certification: 18-month head start on US competitors
Open-source AI stack: No vendor lock-in, full control, lower costs
Integration network: API partnerships with wearable ecosystem
Biological age benchmark: Community comparison data increases value with scale

Slide 15: Team

Essential credibility signals:

Founder 1: Technical (AI/ML + health data engineering)
Founder 2: Domain (clinical background, longevity medicine, or health system experience)
Founder 3: Commercial (B2C growth, wearable/health-tech GTM experience)
Advisory board: Named longevity physicians, EU AI Act regulatory expert, wearable API engineers. Securing executive AI advisory early can also signal deep strategic thinking to investors.
Prior exits or notable experience: Emphasize cross-industry credibility transfer (the "Uber-to-health" pattern from successful decks)

Slide 16: The Ask

Amount: €1.5–2.5M pre-seed / seed
Use of funds:
- 40% — Engineering (data pipeline, AI engine, mobile app)
- 20% — Clinical partnerships + evidence generation
- 15% — Compliance & certification (GDPR, AI Act prep, SOC 2)
- 15% — Go-to-market (community building, influencer seeding, content)
- 10% — Operations + legal
Milestones this funding achieves:
1. MVP with 3 wearable integrations + lab ordering
2. 5,000 beta users with 60%+ weekly retention
3. Published pilot data (biological age tracking validation)
4. EU AI Act pre-certification assessment complete
5. Seed extension or Series A ready

Appendix: Optional Healthcare Module Slides

Module A: Regulatory Pathway (if pursuing SaMD)

Classification: EU MDR Class IIa (decision-support software)
AI Act: High-risk AI system (healthcare decision support)
Timeline: CE marking path with Notified Body engagement
FDA: If US expansion, likely De Novo pathway for AI health recommendations

Module B: Reimbursement Strategy

Phase 1: D2C (no reimbursement needed)
Phase 2: HSA/FSA eligibility (Letter of Medical Necessity pathway)
Phase 3: Employer wellness benefits integration
Phase 4: CMMI ACCESS Model participation (US Medicare, launching July 2026)

Module C: Data Governance Deep Dive

Data flow diagram: Device → Encrypted sync → EU cloud → AI processing → Insight delivery
Consent management: Granular opt-in per data source
Anonymization: Differential privacy for community benchmarks
Audit trail: Every AI recommendation logged with reasoning chain
User controls: Export, delete, restrict processing at any time